Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Summit Therapeu ADR (SMMT)

Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street Motley Fool - Mon Jun 17, 4:50AM CDT

These high-flying stocks could have more room to run if analysts are right.

MRK : 125.77 (+1.22%)
SMMT : 8.78 (-9.90%)
SMCI : 796.78 (-0.60%)
VKTX : 50.90 (+1.60%)
Summit Therapeutics Stock Jumps as Lung Cancer Treatment Gains Traction Baystreet - Fri May 31, 9:36AM CDT

Summit Therapeutics (NASDAQ:SMMT) is a Miami-based biopharmaceutical company that is focused on discovery, ...

SMMT : 8.78 (-9.90%)
Why Summit Therapeutics Stock Is Sinking Today Motley Fool - Tue May 28, 11:13AM CDT

Investors continue to react negatively to recent late-stage results for Summit's experimental cancer therapy.

SMMT : 8.78 (-9.90%)
Charts, tickers, traders - shutterstock_1670814547
5 Top-Rated Russell 2000 Stocks Crushing the Market in 2024 Barchart - Sun Apr 28, 8:30AM CDT

With the Russell 2000 index taking a dip in 2024, these five top-rated RUT stocks are outshining their parent index and the broader market.

$SPX : 5,505.00 (-0.71%)
IWM : 216.84 (-0.51%)
GS : 484.93 (-0.26%)
AVO : 10.80 (-1.46%)
GEO : 16.34 (-2.21%)
LE : 17.03 (+0.59%)
PAYS : 5.15 (+0.98%)
SMMT : 8.78 (-9.90%)
Why Summit Therapeutics Stock Crushed the Market This Week Motley Fool - Fri Mar 29, 4:43PM CDT

The company was a standout in the biotech field, rising by nearly 23% over the period.

SF : 83.22 (+0.31%)
SMMT : 8.78 (-9.90%)
SMMT
Chart of the Day: Summit Therapeutics Begins to Soar Barchart - Thu Jan 25, 7:00AM CST

Caution: This company has had legal issues in the past. It is highly speculative. The Chart of the Day belongs to the oncology company Summit Therapeutics (SMMT) . I found the stock by using Barchart's...

SMMT : 8.78 (-9.90%)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Summit Therapeutics Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors PR Newswire - Mon Jul 10, 2023

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

SMMT : 8.78 (-9.90%)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Summit Therapeutics Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors PR Newswire - Mon Jun 5, 2023

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

SMMT : 8.78 (-9.90%)
Why Shares of Summit Therapeutics Slumped on Tuesday Motley Fool - Tue May 16, 2023

The company's shares have been falling since it announced earnings late last week.

SMMT : 8.78 (-9.90%)
Why Shares of Summit Therapeutics Soared This Week Motley Fool - Fri May 5, 2023

Summit Therapeutics advanced its lead therapy into two phase 3 trials to treat non-small cell lung cancer.

SMMT : 8.78 (-9.90%)

Barchart Exclusives

Stocks Set to Open Higher After Biden’s Withdrawal, Earnings and Key U.S. Inflation Data in Focus Barchart - 41 minutes ago
September S&P 500 E-Mini futures (ESU24) are up +0.47%, and September Nasdaq 100 E-Mini futures (NQU24) are up +0.59% this morning as investors looked past Joe Biden’s exit from his presidential reelection campaign and awaited a slew of corporate earnings reports, with a particular focus on results from “Magnificent Seven” companies Tesla and Alphabet, as well as the release of the Fed’s preferred inflation gauge later in the week. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot